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Total infant mortality in Hungary has been higher than other European countries; however,
the reported incidence of sudden infant death syndrome (SIDS) has been lower. The
low incidence of SIDS in Hungary has been supported by evidence obtained from the
high rate of scene of death investigation and medico-legal autopsy mandatory since the
1950s. In this study, we compared the incidence of explained and unexplained infant
deaths in Hungary for three periods: 1979–1989 when the incidence of SIDS was high
in western Europe; 1990–1999 when the incidence of infant deaths was falling following
introduction of the public health campaigns to reduce the risk factors associated with
SIDS; and 2000–2012 to determine if introduction of Haemophilus influenzae type b or
pneumococcal vaccines or introduction of an earlier immunization schedule during this
period had an effect on SIDS. Explained infant deaths fell consistently during this period;
however, SIDS rose during the second period when the incidence of SIDS was falling in
other European countries. Evidence for infection and/or inflammation was observed for
themajority of SIDS during each period. The results are discussed in relation to campaigns
to reduce infant mortality in Hungary and the introduction of new vaccines and an earlier
immunization schedule in 2006.
Keywords: sudden infant death syndrome, infant mortality, immunization, infection, inflammation
Introduction
In 2004, we reported that infant mortality in Hungary was higher than many European countries
(1) (Figure 1) and it has remained high according to the OECD figures for 2014 (2); however, the
reported incidence of sudden infant death syndrome (SIDS) has been lower (0.15–0.3/1000 live
births) than those of other countries (1, 3, 4). The historically low incidence of SIDS in Hungary
has been supported by evidence obtained from the high rate of scene of death investigation and
medico-legal autopsy.
It was reported that prior to 1980, the incidence of SIDS was lower in East Germany and this
was attributed to a lower prevalence of prone sleeping compared with figures forWest Germany (5).
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FIGURE 1 | Comparison of infant mortality (per 1000 live births) for Hungary and the European Union (data from the WHO Regional Office for Europe).
SIDS has many risk factors that parallel susceptibility to infec-
tious diseases, and there is increasing evidence that infection and
inflammatory responses play a role in the events leading to these
deaths (Blackwell et al., this issue). During 1983–1989, the inci-
dence of SIDS inNorway and Sweden appeared to parallel the inci-
dence of whooping cough. Mortality rates followed significantly
the monthly prevalence of Bordetella pertussis in Sweden where
immunization for pertussis had been discontinued. In Norway
where pertussis immunizationwas continued, this correlationwas
less obvious (6).
In relation to these observations, it has been suggested that
the historic emphasis on infant immunization in Hungary might
have contributed to the lower incidence of suddendeaths triggered
by infectious agents. Immunization began in the late eighteenth
century with variolization. Immunization with vaccinia replaced
this practice, and the first mandatory vaccine for children in
Hungary was for small pox in 1876. Tetanus toxoid was offered
from 1940, but this was not mandatory.
A national immunization plan (NIP) has been in effect in
Hungary since the mid-1950s and mandatory since its introduc-
tion; costs are covered by the national budget and exemptions
are allowed only for medical reasons. The NIP began with uni-
versal BCG vaccine for infants at the maternity hospitals prior
to discharge. This was followed by diphtheria-pertussis (whole
cell)-tetanus (DPT), subsequently replaced in 2006 by an acellular
pertussis vaccine. Immunizations were at 3, 4, and 5months, with
boosters at 3 and 6 years until 2006. Since then, the primary doses
are given at 2, 3, and 4months, and the boosters are given at
18months and 6 years.
Haemophilus influenzae type b (Hib) prophylaxis began in 1999
(3, 4, and 5months) in conjunction with DPT immunization. In
2006, the combined acellular DPT, inactivated polio and Hib vac-
cine was introduced. Pneumococcal conjugate vaccine (7-valent)
was introduced in 2008 at 2, 4, and 18months. It was free but not
mandatory; however, the uptake was 83% for all eligible infants.
The 7-valent vaccine was replaced by the 13-valent n in 2010.
The current study compared explained deaths due to infection
and those due to SIDS in three periods: 1979–1989 when the
incidence of SIDSwas higher in western Europe; 1990–1999 when
the incidence of infant deaths was falling following introduc-
tion of the public health campaigns to reduce the risk factors
identified for SIDS (e.g., prevention of prone sleeping, over-
heating, and exposure to cigarette smoke); and 2000–2012 to
determine if introduction of Hib or pneumococcal vaccines had
an effect on SIDS. Available autopsy records were assessed for
evidence of infection and inflammation among infant deaths in
these three periods. As initiation of infant immunization in the
United Kingdom was associated with a shift in the age ranges
of SIDS infants (7, 8), data on age of SIDS infants in cen-
tral Hungary were analyzed to determine if there was a similar
decrease in the proportion of SIDS infants in the age range of
3–4months following the change to the earlier immunization
schedule.
Materials and Methods
In Hungary since the 1950s, all sudden infant deaths are referred
for medico-legal investigations and autopsy. Data on SIDS and
deaths due to infection were collected from the Hungarian
National Statistics Office Database for three periods: period 1,
1979–1989; period 2, 1990–1999; and period 3, 2000–2012. The
ninth and tenth revisions of the international classification of
diseases (ICD) were used for the determination of cause of death
(Table 1). SIDS cases were classified as 798.0 (ICD version ninth)
or R95 (ICD version tenth). ICD codes are derived from the
autopsy records and death certificates. The ninth version cov-
ered the years between 1979 and 1995. The tenth version was
introduced in 1996.
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TABLE 1 | Selected ICD codes versions 9 and 10 reflected to the infections
in different organs.
ICD code version
9 10 Cause of death
001–139 A00–B99 Certain infections and parasitic diseases
320–357 G00–G08 Diseases of the nervous system
360–389 H65–H70 Diseases of the ear and mastoid process
460–519 J01–J69 Diseases of the respiratory system
520–579 K35–K75 Diseases of the digestive system
580–629 N10–N39 Diseases of the genitourinary system
682–709 L00–L99 Diseases of the skin and subcutaneous tissue
710–739 M00–M99 Diseases of the musculoskeletal system
760–779 P23–P77 Certain conditions originating in the perinatal period
798.0 R95 Sudden infant death syndrome
Sudden infant death syndrome cases were diagnosed by the
currently accepted definition (9). If severe inflammation or signs
of septicemia were noted, these cases were not classified as SIDS.
Infection and inflammation in different organ systems were ana-
lyzed and assigned to ICD codes (Table 1).
Results
In the three time periods, there were 47412 infant deaths: period
1, 26124; period 2, 13433; and period 3, 7855. In each period,
the majority of deaths were explained and a small number were
classified as SIDS: period 1, 251 (0.9%); period 2, 331 (2.4%);
and period 3, 271 (3.4%). For each period, there was an excess of
male deaths among the SIDS infants: period 1, 155 (62%)male, 96
(38%) female); period 2, 193 (58%) male, 138 (42%) female; and
period 3, 154 (57%) male, 117 (43%) female (Table 2). Most SIDS
cases (70%) occurred between 2 and 6months of age. The rate of
mild infections among SIDS victim under 6months old was 70%,
while the proportion was only slightly lower (60%) among older
SIDS infants.
Respiratory infections (J01–J69) were the most common cause
of death in all three periods; however, there was a steady decline,
particularly after the introduction of the Hib vaccine in 1999 and
the pneumococcal vaccine in 2006 (Figure 1). For each of the
three periods, therewas a higher proportion ofmales than females;
however, the difference was not significant.
In contrast to the steady decline in deaths due to respiratory
infections, there was an increase in the number and proportion
of SIDS deaths in period 2 (2.4%) compared to those of period
1 (0.9%). This was followed by a decrease in numbers of SIDS in
period 3, but an increase in the proportion of total deaths (3.4%)
(Figures 2A,B). The increase in SIDS cases in the second period
was the opposite of the decrease in SIDS cases in other countries
in Europe. While the average SIDS per 1000 live births was 0.235,
males were more likely to die of SIDS (0.268) than females (0.2),
(Figure 3).
Among the explained deaths, the proportion in which infection
was identified decreased significantly from 13.6% in period 1 to
8.4% in period 3 (X2= 168.9, df= 2, p= 0). As noted in themeth-
ods, if severe inflammation or signs of septicemia were noted,
these cases were not classified as SIDS. For SIDS, the proportion of
infants with evidence of mild infection did not vary significantly:
66% in period 1; 65% in period 2, and 58% in period 3 (X2= 4.57,
df= 2, p= 0.1) (Table 3).
A decrease in SIDS noted in the United Kingdom following ini-
tiation of infant immunization at 2months rather than 3months,
particularly in the age range of 3–4months. Between 1994 and
2012, there were 114 SIDS in the Budapest-Central Hungary area;
70 between 1994 and 2005 and 44 between 2006 and 2012. The
immunization of infants at 2months of age began in 2006. As with
figures reported for the UK, the greatest decrease in SIDS was
noted for children aged 3months 14/70 (20%) prior to change in
the immunization schedule to 2/42 (4.5%) in the second period
(Fishers exact probability test, two tailed 0.026). While the num-
bers were small, they reflected the pattern noted in other studies.
Discussion
In Hungary in the first and second periods examined, the main
focus was to reduce infant mortality from known causes; it was
much higher than in western European countries (1). The main
strategy was to reduce perinatal mortality. Prevention of infec-
tions through immunizationwas an important part of this strategy
and deaths from infection have declined (Table 1;Figure 2). These
efforts were reflected in reduction in deaths due to meningi-
tis, septicemia, and pneumonia. In contrast to other European
countries, there was an increase in the proportion of SIDS in
period 2 (1990–1999), followed by a decrease in period 3. For
periods 1 and 2, evidence of mild infection was noted for over
60% of unexplained infant deaths investigated compared to 13.6
and 10.9% for infectious deaths in the comparable periods. In
studies in the 1990s, Streptococcus pneumoniae was isolated from
a significantly higher proportion of SIDS infants (11%) compared
to healthy infants matched for age, sex, and locality (10). While
rare, pneumococcal infections have been implicated in sudden
infant deaths (11). It was noted in our data that there was a
sharp decline in SIDS following introduction of the pneumococcal
vaccine in 2008 (Figure 3) and it has remained below the numbers
prior to 2008. Although the numbers were small, the decrease in
the numbers of deaths at 3months also decreased dramatically
following initiation of infant immunization at 2months in 2006
and, while the numbers are small they have not returned to levels
noted prior to 2006.
There was no year when the SIDS rate per 1000 live births was
more than 0.4/1000. The increase in SIDS in Hungary was not
expected and requires investigation. There are several factors to
be considered.
In the 1990s, there was a campaign based on studies in other
countries to reduce the risk factors for SIDS. There have been no
case-control studies inHungary similar to those in other countries
on which the “reduce the risks” campaigns were based. In Hun-
gary, the prone sleeping position was not widely accepted as a real
risk factor for SIDS. The risk factors for SIDSmostwidely accepted
as significant were infection, lack of immunization, crowded liv-
ing conditions associated with lower social-economic status, and
exposure to cigarette smoke.
Reduction of exposure of infants to cigarette smoke was
strongly emphasized in the campaign; however, compared to
statistics available for Britain, the proportion of women in
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TABLE 2 | Number of deaths during the three periods assessed by ICD classification and gender.
Number of deaths (%)
Selected ICD codes 1979–1989 1990–1999 2000–2012 1979–2012
Male Female Male Female Male Female Male+ Female
A00–B99 135 (0:9) 109 (1:0) 112 (1:5) 67 (1:2) 40 (0:9) 27 (0:8) 490 (1:0)
G00–G08 176 (1:2) 153 (1:4) 100 (1:3) 76 (1:3) 32 (0:7) 29 (0:8) 566 (1:2)
H65–H70 184 (1:2) 130 (1:2) 39 (0:5) 37 (0:6) 12 (0:3) 15 (0:4) 417 (0:9)
J01–J69 1144 (7:7) 797 (7:1) 423 (5:6) 262 (4:5) 111 (2:6) 82 (2:3) 2819 (5:9)
K35–K75 81 (0:5) 57 (0:5) 23 (0:3) 16 (0:3) 6 (0:1) 4 (0:1) 187 (0:4)
N10–N39 10 (0:1) 9 (0:1) 11 (0:1) 5 (0:1) 1 (0:0) 1 (0:0) 37 (0:1)
L00–L99 6 (0:0a) 4 (0:0a) 0 (0:0) 1 (0:0a) 0 (0:0) 0 (0:0) 11 (0:0a)
M00–M99 0 (0:0) 1 (0:0a) 0 (0:0) 0 (0:0) 1 (0:0a) 0 (0:0) 2 (0:0a)
P23–P77 488 (3:3) 361 (3:2) 235 (3:1) 184 (3:2) 235 (5:4) 205 (5:8) 1708 (3:6)
R95 155 (1:0) 96 (0:9) 193 (2:5) 138 (2:4) 154 (3:6) 117 (3:3) 853 (1:8)
TOT 14949 11175 7617 5816 4316 3539 47412
aPercentage <0.1%.
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FIGURE 2 | Percentage distributions deaths due to respiratory diseases (J01–J69). (A) Number of SIDS cases in the three periods investigated. (B) Number
of SIDS cases per years between 1979 and 2012.
Hungary who smoke has not changed from themid-1970s. Smok-
ing among women decreased in the UK from 41% in 1974 to 17%
in 2013 (12). For Hungary, there has not been a similar decline:
22% of women smoked in 1975 and 24% smoked in 2012 (13).
During and after the campaign, pathologists and forensic
pathologists began to accept more widely that SIDS is a credible
diagnosis. Documentation and the scene of death investiga-
tion became much more rigorous, not only to exclude infanti-
cide or accidents but also to obtain data on symptoms of ill-
ness prior to death, prenatal and postnatal diseases, and dis-
orders in development. Investigation focused not only on the
pathomorphological changes but also evaluated the history of
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FIGURE 3 | Distribution of SIDS cases per 1000 live births 1979–2012.
TABLE 3 | Analyses of evidence of infection in infant deaths in Hungary.
1979–1989
No (%)
1990–1999
No (%)
2000–2012
No (%)
Explained* 25873 13202 7584
Infection 3521 (13.6) 1451(10.9) 637 (8.4)
Unexplained (SIDS) 251 331 271
Mild infection 166 (66) 215 (65) 157 (58)
*Microbiologically confirmed and accepted.
pregnancy and delivery. Postmortem microbiology was also
introduced.
Although there was no standard autopsy protocol, the autopsy
and histology in every case of sudden infant death is compul-
sory. Due to the increase in emphasis on accurate diagnosis, the
possibility of change in diagnosis or bias cannot be ruled out;
however, the age range affected, the excess of male deaths, and
the pathomorphology (congested lungs, number and distribution
of petechiae, liquid heart blood) were similar to those observed in
Hungary prior to the intervention and in other countries. While
the proportion of infection-related explained deaths declined dur-
ing the three periods studied, the proportion of SIDS infants with
evidence of minor infection/inflammation remained constant at
approximately 60%.
There is evidence of infection in many of these infants. Bac-
teria or nuclear bodies in some indicating viral infections can
be demonstrated microscopically. Bacterial and viral cultures
have not been given much weight in assessment of SIDS because
of the concern that the organisms are contaminants or over-
growth of normal flora and not related to the cause of death.
More recent studies have identified bacteria in normally sterile
sites in investigations of sudden death in infancy (14–16). Most
of these organisms do not continue to grow when a body is
stored at 4°C. In addition, staphylococcal toxins produced only
at temperatures between 37 and 40°C have been identified in
significant proportions of SIDS infants from different countries
including Hungary (17) and toxigenic enteric organisms have
also been identified in these infants (Bettelheim and Goldwa-
ter, this issue). Recent studies have indicated that virus infec-
tions might enhance inflammatory responses to mild bacterial
infections (Moscovis et al., this issue). Autopsies need to include
assessment of the molecular signs of inflammation such as
cytokines that can affect the various physiological mechanisms
proposed to explain these deaths (Blackwell et al., this issue).
In recent years, the autopsy rates in many countries have
decreased, including Hungary. This is unfortunate as there is
a growing persuasive argument for including new investigative
techniques that could contribute to explaining the cause of these
deaths: genetic investigations (Morris, this issue); and detailed
microbiological investigations, both conventional diagnostic pro-
cedures and more extensive molecular screening techniques
(Goldwater, this issue; Bettelheim and Goldwater, this issue).
Conclusion
The current study compared explained deaths due to infection and
those due to SIDS in three periods: 1979–1989when the incidence
of SIDS was higher in western Europe; 1990–1999 when the
incidence of infant deathswas falling following introduction of the
public health campaigns to reduce the risk factors identified for
SIDS (e.g., prevention of prone sleeping, overheating, and expo-
sure to cigarette smoke); and 2000–2012 to determine if introduc-
tion ofHib or pneumococcal vaccines had an effect on SIDS. There
were reductions in SIDS cases identified following introduction
of the Hib vaccine in 1999, introduction of the earlier immu-
nization schedule in 2006, and introduction of immunization for
pneumococcus in 2008. While reduction of prone sleeping or
overheating cannot be ruled out as contributing to these decreases,
the proportion of mothers who smoked remained constant. The
evidence for infection/inflammation in explained deaths declined
significantly over the three periods studied. Evidence of inflam-
mation/infection in SIDS cases remained steady. Initiation of
infant immunization in the United Kingdom at 2months was
associated with a shift in the age ranges of SIDS infants (7, 8), and
although the numbers were small, there was a similar pattern of a
sharp decline among infants who died at 3months of age.
According to a recent study, the component of the post-
mortem examination that was the most helpful in diagno-
sis was the histological examination, followed by macroscopic
examination, microbiological investigations, and clinical history.
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The majority of infection-related diagnoses were identified pri-
marily by histological sampling rather than microbiological anal-
yses, although microbiology aided in a diagnosis for 20% of cases
that would have otherwise gone undetected (14). While autopsy
findings have varied, signs of inflammation and responses to
infection have appeared out of proportion to preexisting symp-
toms. The increase in inflammatory markers found in SIDS
infants indicates that infection and inflammation might con-
tribute to some of these deaths, either as a direct cause or the
trigger of a lethal event. It might also be indicative of vulnera-
bility in the immune response to an infectious trigger in infants.
The protective effects of immunization (18, 19) noted for SIDS is
further evidence for infection/inflammation playing a role in these
infant deaths.
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